William Smead
Chief Executive Officer
Chief Investment Officer

Dear Fellow Investors:

When I was 5 years old I got a life saver stuck in my throat while grocery shopping with my parents. My Dad grabbed me by the ankles and turned me upside down. He shook me a couple of times until the sweet lozenge dislodged. We just did the same thing in the US stock market in the last week.

We at Smead Capital Management believe that the market has an uninterrupted BRIC trade lozenge stuck in its throat. This lozenge causes the US stock market to choke on over-priced oil, basic materials and industrial shares. While we are seeing a textbook economic recovery, we are using much less gasoline than a year ago. We are also embarking into the world of electric cars. Why is the price of a commodity going up when its best customer is using less?

In our opinion, the answer is that the capital market participants believe as deeply in uninterrupted growth in China as I believed in the good flavor of orange and cherry flavored life savers at age five. The only way to get it out of me was to shake me and the only way to change the investment trend is to shake it with high volatility. The Chinese stock market, as represented by the Shanghai Composite, fell 1.9% last night in overseas trading. That’s a decline of 20% in the last nine months, qualifying for bear market territory. Stock markets have a tendency to look out one year on economic activity.

Ignore the noise and enjoy owning America’s fine companies in areas like consumer, banking and healthcare. When we get this BRIC trade out of our throats, we believe under-priced non-cyclicals will take over market leadership.

Best Wishes,

William Smead

The information contained in this missive represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. Some of the securities identified and described in this missive are a sample of issuers being currently recommended for suitable clients as of the date of this missive and do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.

We Advise Investors

Sign up to get our advice sent straight to your inbox.

Recent Missives

4Q24 International Value Strategy Newsletter: Paku Paku: Swallowing Like Pac-Man

January 15, 2025

[...] Investors and management teams often forget that the stock market isn’t a game of you versus them. It’s a game of you versus you. Mr. Market comes to you every day with...

⟶ Keep Reading

4Q24 U.S. Value Strategy Newsletter: Reasonableness

January 15, 2025

[...] Back in 2012, our portfolio traded at 12-times profits versus 14-times for the S&P 500 Index. The spread allowed us to compete very favorably with the S&P 500 Index in an era...

⟶ Keep Reading

BNN Bloomberg: Cole Smead, CFA on Chevron-Hess Spat

January 10, 2025

    Chevron-Hess spat likely to spike more mergers For more information go to www.bnnbloomberg.ca. Stocks mentioned: CVE The information contained in this article represents SCM’s opinions, and should not be […]

⟶ Keep Reading

USA Today: CIO Bill Smead on Narrow Group of Stocks in the S&P 500

January 3, 2025

Stocks tumble Tuesday: ‘canary in the cold mine’ as inflation bubbles higher By Andrea Riquier For more information go to www.usatoday.com. The information contained in this article represents SCM’s opinions, […]

⟶ Keep Reading

Bloomberg Businessweek Podcast: Bill Smead on a Major Financial Euphoria Episode

January 2, 2025

  Bloomberg Businessweek Podcast Hosted by Carol Massar and Tim Stenovec   The information contained in this interview represents SCM’s opinions, and should not be construed as personalized or individualized […]

⟶ Keep Reading

Dissecting Our Discipline

January 2, 2025

All portfolio managers practice a stock-picking discipline in which they make choices. Growth stock investors attempt to predict which companies will grow the most in the future and compare the growth they expect...

⟶ Keep Reading

We Advise Investors

Sign up to get our advice sent straight to your inbox.

US INVESTORS

Individual Investors

OR

Financial Advisors, Family Offices,
and Institutional Investors

OR

NON-US INVESTORS

Individual Investors

OR

Financial Advisors, Family Offices,
and Institutional Investors

OR

Scroll to Top